Categories

September 2025

Alert
Series Articles of the Regenerative Medicine Dual Legislation (9) – The Final Step of Taiwan’s Regenerative Medicinal Products Act: Draft Announcement of the Regulations for Registration of Regenerative Medicinal Products

Teresa Huang

Oli Wong

David Hung

September 2025

Alert
Series Articles of the Regenerative Medicine Dual Legislation (8) – "Regulations for Regenerative Medicine Techniques to Determine Tissue and Human Cell Donor Suitability" and "Fee-charging Standards for the Review of Regenerative Medicine Applications and Advertisement Publication" Announced

Teresa Huang

Oli Wong

David Hung

June 2025

Alert
Series Articles of the Regenerative Medicine Dual Legislation (7) – Draft Regulations on Cell Processing and Cell Bank Licensing Announced: Regenerative Medicine Act Taking Shape (Taiwan)

Teresa Huang

Oli Wong

David Hung

June 2025

Alert
Series Articles of the Regenerative Medicine Dual Legislation (6) – Clarifying Donor Eligibility and Fee Standards: Supporting Regulations Under the Regenerative Medicine Products Act Released (Taiwan)

Teresa Huang

Oli Wong

David Hung

May 2025

Alert
Brief Introduction to the Evolution of Foreign Capital Access Policy Governing China's Human Stem Cell and Gene Therapy (CGT) and the Key Points of Enterprise Compliance Supervision

Joyce Wen

Teresa Huang

April 2025

Alert
The Ministry of Health and Welfare of Taiwan Issued the Operational Principles for the Temporary Payment of New Cancer Drugs

Teresa Huang

David Hung